# Rishena

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rishena

- Industry: Medical Devices & Equipment
- Headquarters: Changzhou, China
- Website: www.rishena.com
- Total disclosed funding: $2.2M
- Latest round: Series A (Dec 1, 2021)
- Investors on record: 3

## About

Established in 2013 and based in Changzhou, China, Rishena is a medical device company that focuses on the research and development of active implantable medical devices. In 2014, the company obtained the production license of three types of medical devices. In 2015, it obtained the inspection reports of VNS and GES products. In 2021, the company launched a non-implantable concha vagus nerve stimulator (tVNS501) and SEL-4XX series intracranial brain electrodes (SEEG). In May 2023, it raised an undisclosed amount of strategic investment from new investor Proxima Ventures.

The company's main products include implantable vagus nerve stimulator (VNS), implantable rechargeable spinal cord stimulator (SCS) and concha vagus nerve stimulator (t-VNS), etc. The implantable vagus nerve stimulator consists of three parts: a stimulator assembly, an electrode lead assembly, and a neural regulation program controller. Its products are used in conditions such as epilepsy and Parkinson's disease.

## Funding rounds

- Series A, Dec 1, 2021, $2.2M — Yushan Partners
- Series A, Oct 23, 2019 — Rays Venture Capital, apon

## Investors

- Rays Venture Capital (https://capitalatlas.ai/funds/rays-venture-capital) — Series A
- apon — Series A
- Yushan Partners (https://capitalatlas.ai/funds/yushan-partners) — Series A